Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects.
about
Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts.M-CSF improves protection against bacterial and fungal infections after hematopoietic stem/progenitor cell transplantation.CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
P2860
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@ast
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@en
type
label
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@ast
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@en
prefLabel
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@ast
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@en
P2093
P356
P1476
Phase I trial of subcutaneous ...... and immunomodulatory effects.
@en
P2093
J A Gibbons
R M Bukowski
P304
P356
10.1200/JCO.1994.12.1.97
P407
P577
1994-01-01T00:00:00Z